Skip to Main Content

Paper Details

Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis.
BMC Cancer
2
2023
Author NameAffiliation
Katherine G Akers
Peter A FaschingComprehensive Cancer Center Erlangen, University Hospital Erlangen, Friedrich-Alexander University Erlangen
  • 1 - 2

Datasets

Release 1.2